Fiche de révision : Lung Pathology and Disease Mechanisms

Course Outline

  1. Tuberculosis pathophysiology
  2. Reinfection and reactivation
  3. Spread of tuberculosis
  4. Tuberculosis clinical features
  5. Tuberculosis diagnosis and treatment
  6. Bronchiectasis causes and morphology
  7. Bronchiectasis clinical features and management
  8. Lung cancer types and spread
  9. Environmental lung diseases
  10. Pneumoconiosis and asbestosis
  11. Silicosis features and effects
  12. Parenchymal lung diseases and fibrosis

1. Tuberculosis pathophysiology

Key Concepts & Definitions

Granuloma formation (implied in the context of immune response): An organized collection of immune cells, primarily macrophages, that surround and contain the Mycobacterium tuberculosis infection within tissues, aiming to limit its spread.

Caseous necrosis (within granulomas): A distinctive form of tissue death characterized by a soft, cheese-like appearance, occurring inside granulomas as a result of the immune response to TB infection.

Pathogenesis of TB involving alveolar macrophages: The process by which Mycobacterium tuberculosis enters the body, travels to alveoli, and is ingested by alveolar macrophages, which are unable to destroy the bacteria, leading to an inflammatory response and granuloma formation.

Essential Points

  • TB enters the body and reaches alveoli, where alveolar macrophages attempt to phagocytose the bacteria but fail to destroy them.
  • The immune response involves neutrophils, T-cells, and additional macrophages, leading to granuloma formation aimed at containing the infection.
  • Inside granulomas, the immune cells surround the bacteria; this environment can undergo caseous necrosis, giving the granuloma a cheese-like appearance.
  • Granulomas serve as a protective mechanism but can become reactivated, especially in immunocompromised individuals, leading to re-infection or reactivation.
  • The immune response and granuloma formation are central to the pathogenesis of TB, with caseous necrosis being a hallmark feature within granulomas.

Key Takeaway

Granuloma formation is the body's immune attempt to contain Mycobacterium tuberculosis, often featuring caseous necrosis within the granuloma, which reflects the ongoing battle between the pathogen and host defenses involving alveolar macrophages.

2. Reinfection and reactivation

Key Concepts & Definitions

Reactivation | The process where a granuloma that was previously formed to contain Mycobacterium tuberculosis becomes active again, leading to renewed disease. It occurs when the immune system is compromised, allowing dormant bacteria to become active and spread.

Reinfection | The occurrence of new infection with Mycobacterium tuberculosis in an individual who is immunocompromised, resulting in the bacteria becoming active again and spreading, even if a prior granuloma was formed. It involves the bacteria becoming active again and spreading.

Essential Points

  • Reactivation typically happens in immunocompromised individuals, where previously contained granulomas become active again, allowing bacteria to spread.
  • Reinfection also occurs mainly in immunocompromised persons, where new bacteria infect the host and cause active disease.
  • Both processes involve bacteria becoming active again and spreading, but reactivation refers to the reactivation of dormant bacteria within existing granulomas, while reinfection involves new bacterial infection.
  • Reactivation may lead to secondary tuberculosis, characterized by the bacteria becoming active again and spreading.
  • Reinfection signifies a new infection in an individual with compromised immunity, leading to active disease.

Key Takeaway

Reactivation involves dormant bacteria within granulomas becoming active again, often due to immune compromise, whereas reinfection refers to new bacterial infection leading to active disease in immunocompromised individuals.

3. Spread of tuberculosis

Key Concepts & Definitions

  • Direct Spread: Transmission of TB infection through contact with infected pleura or pericardium, leading to localized infection in these areas.

  • Via Bronchi: Spread of TB from the lungs to the larynx or other bronchi, potentially causing TB bronchopneumonia and large areas of lung consolidation.

  • Through Pulmonary Veins: Dissemination of TB bacteria into the bloodstream via pulmonary veins, resulting in blood-borne infections such as TB meningitis, renal, and bone TB.

  • Blood-borne dissemination of TB: The process where TB bacteria enter the bloodstream and spread to various organs, causing systemic infections.

  • Lymphatic spread of TB: Movement of TB bacteria through lymphatic channels, leading to infection in lymph nodes and other tissues.

Essential Points

  • TB primarily involves the lungs but can affect any organ or tissue via different spread mechanisms.
  • Spread occurs through several routes:
    • Direct spread affects pleura and pericardium.
    • Via bronchi can lead to TB bronchopneumonia and large lung consolidations.
    • Pulmonary veins facilitate blood-borne dissemination, spreading TB bacteria to distant sites like the meninges, kidneys, and bones.
    • Pulmonary arteries are involved in the vascular spread, possibly through lymphatic drainage into the inferior vena cava.
  • Re-infection can occur in immunocompromised individuals, with bacteria reactivating and spreading again.
  • Clinical features and diagnosis depend on the spread route, with systemic dissemination often leading to severe complications.

Key Takeaway

TB spreads through multiple routes—direct contact, airways, blood, and lymphatics—allowing it to infect localized areas or disseminate systemically, which influences clinical presentation and disease severity.

4. Tuberculosis clinical features

Key Concepts & Definitions

  • Chronic cough: A persistent cough lasting longer than three weeks, commonly seen in tuberculosis due to ongoing lung inflammation and infection.
  • Hemoptysis: Expectoration of blood, which occurs when tuberculosis causes erosion of blood vessels within the lung tissue.
  • Systemic symptoms: General signs indicating systemic involvement, including fever, anorexia, malaise, and night sweats, reflecting the body's response to infection.
  • Radiological features:
    • Consolidation: An area of lung tissue filled with liquid or solid material, appearing as a dense region on imaging, indicative of alveolar filling.
    • Cavitation: Formation of a cavity within lung tissue, often due to caseous necrosis within granulomas, characteristic of active tuberculosis.

Essential Points

  • Clinical features include a chronic cough and hemoptysis, often accompanied by systemic symptoms such as fever, anorexia, malaise, and night sweats.
  • Radiological findings are crucial for diagnosis, with consolidation indicating large areas of lung parenchyma affected and cavitation representing necrotic destruction within granulomas.
  • The presence of cavitation is associated with active disease and may facilitate the spread of infection.
  • These features are key for identifying active tuberculosis and assessing disease severity.

Key Takeaway

Tuberculosis typically presents with a chronic cough, hemoptysis, systemic symptoms, and characteristic radiological features like consolidation and cavitation, which are essential for diagnosis and disease assessment.

5. Tuberculosis diagnosis and treatment

Key Concepts & Definitions

Mantoux skin test | A diagnostic tool involving intradermal injection of purified protein derivative (PPD) to detect delayed hypersensitivity reaction indicative of TB exposure. A positive test suggests prior exposure or infection.

ESR (Erythrocyte Sedimentation Rate) | A blood test measuring the rate at which red blood cells settle in a period of one hour. Elevated ESR indicates inflammation, which can be associated with active tuberculosis.

Chest X-ray for diagnosis | An imaging modality used to identify pulmonary involvement in TB, showing features such as consolidation, cavitation, or infiltrates, especially in the lung zones.

Use of antituberculosis drugs in treatment | Pharmacological therapy involving specific medications aimed at eradicating Mycobacterium tuberculosis, typically including multiple drugs over an extended period to prevent resistance and ensure cure.

Essential Points

  • The Mantoux skin test detects immune response to TB antigens; a positive result supports TB exposure but does not distinguish between latent and active disease.
  • ESR is a supportive diagnostic marker; increased ESR suggests active inflammation but is non-specific.
  • Chest X-ray aids in visualizing lung lesions characteristic of TB, such as consolidation and cavitation, aiding in diagnosis and monitoring.
  • Treatment involves the use of antituberculosis drugs, which are essential for curing TB and preventing spread; the specific drugs and duration are based on disease severity and type.

Key Takeaway

Diagnosis of tuberculosis relies on a combination of immune testing (Mantoux), inflammatory markers (ESR), and imaging (chest X-ray), while effective treatment depends on the appropriate use of antituberculosis medications.

6. Bronchiectasis causes and morphology

Key Concepts & Definitions

  • Permanent dilation of bronchi and bronchioles: A condition characterized by irreversible widening of the airways resulting from destruction of the muscular and elastic supporting tissue (source: "Bronchiectasis — Permanent dilation of Bronchi and Bronchioles").

  • Secondary bronchiectasis due to infection or obstruction: A form of bronchiectasis that develops as a consequence of persistent infection or blockage within the airways, leading to tissue destruction and dilation (source: "Secondary disease due to persistent infection or obstruction").

  • Patchy distribution: The pattern of bronchiectasis where affected areas are irregular and scattered throughout the lungs rather than being uniform or localized to a specific region.

  • Lower lobe predilection: The tendency for bronchiectasis to predominantly affect the lower lobes of the lungs, often due to gravity-dependent factors or regional susceptibility.

Essential Points

  • Bronchiectasis involves the irreversible dilation of bronchi and bronchioles caused by destruction of their muscular and elastic tissue.

  • It is often secondary to other conditions, especially those involving persistent infection or airway obstruction.

  • The distribution of bronchiectasis is typically patchy, with a preference for the lower lobes.

  • The morphological features include dilated bronchi that may appear cylindrical or saccular and are associated with inflammatory exudate, leading to epithelial desquamation and ulceration.

Key Takeaway

Bronchiectasis is a permanent, patchy dilation of the bronchi and bronchioles, predominantly affecting the lower lobes, often as a secondary consequence of infection or obstruction, resulting in structural airway damage.

7. Bronchiectasis clinical features and management

Key Concepts & Definitions

  • Productive cough: A cough that expels mucus or phlegm from the respiratory tract, often seen in bronchiectasis due to mucus accumulation in dilated bronchi.

  • Episodic fever: Recurrent episodes of elevated body temperature, typically associated with infection or inflammation, common in bronchiectasis exacerbations.

  • Hemoptysis: Coughing up blood originating from the respiratory tract, frequently occurring in bronchiectasis due to damaged and inflamed bronchial vessels.

  • Management: postural drainage: A technique involving positioning the patient to facilitate drainage of mucus from the bronchi and bronchioles, aiding in clearance of secretions.

  • Management: antibiotics: Use of antimicrobial agents to treat or prevent bacterial infections in bronchiectasis, especially during exacerbations or persistent infections.

Essential Points

  • Bronchiectasis is characterized by permanent dilation of bronchi and bronchioles caused by destruction of muscles and elastic tissue, often secondary to persistent infection or obstruction.

  • Clinical features include a productive cough, episodic fever, and hemoptysis.

  • Morphologically, affected bronchi are dilated and distended, with a patchy distribution, predominantly in the lower lobes.

  • Inflammatory exudate within the walls causes epithelial desquamation and ulceration, contributing to symptoms and disease progression.

  • Treatment involves postural drainage to aid mucus clearance and antibiotics to control infection.

Key Takeaway

Bronchiectasis presents with productive cough, episodic fever, and hemoptysis, and is managed primarily through techniques like postural drainage and antibiotic therapy to reduce infection and improve airway clearance.

8. Lung cancer types and spread

Key Concepts & Definitions

  • Small Cell Lung Carcinoma: A type of lung cancer characterized by small, round, or oval cells that tend to grow rapidly and metastasize early.
  • Squamous Cell Carcinoma: A lung cancer subtype originating from squamous epithelial cells, often linked to smoking, typically found in central bronchi.
  • Large Cell Carcinoma: An undifferentiated, poorly differentiated lung cancer with large, abnormal cells, usually with rapid growth and early metastasis.
  • Adenocarcinoma: A type of lung cancer arising from glandular epithelial cells, often located peripherally, associated with environmental pollutants and smoking.
  • Spread via Hematogenous Route: Dissemination of tumor cells through blood vessels, leading to metastasis in distant organs such as the brain, bones, or kidneys.
  • Spread via Lymphatic Route: Movement of tumor cells through lymphatic vessels, resulting in regional lymph node involvement and potential distant spread.
  • Common Etiological Factors: Factors contributing to lung cancer development, primarily smoking and pollutants (e.g., industrial or atmospheric pollutants).

Essential Points

  • Lung cancer is the second most common cancer.
  • The main histological types include small cell carcinoma, squamous cell carcinoma, large cell carcinoma, and adenocarcinoma.
  • These types differ in cell origin, growth rate, and pattern of spread.
  • Spread occurs via hematogenous (blood) and lymphatic routes, facilitating metastasis to various organs.
  • Environmental factors such as smoking and pollutants are significant etiological contributors.
  • Gross pathology varies among types but generally involves tumor mass with potential for early metastasis.

Key Takeaway

Lung cancer comprises various histological types with distinct characteristics, primarily spreading through hematogenous and lymphatic routes, with smoking and pollutants being key risk factors.

9. Environmental lung diseases

Key Concepts & Definitions

Lung disease caused by inhalation of mineral dust: A condition resulting from the inhalation of mineral particles such as coal, silica, asbestos, and beryllium, leading to lung tissue damage and fibrosis. (see section 10: Pneumoconiosis)

Impact of occupational exposure on lung health: The effect on lungs due to inhalation of harmful mineral dusts during work activities, which can cause diseases like pneumoconiosis, silicosis, and asbestosis, often leading to fibrosis, respiratory failure, or increased susceptibility to infections such as TB.

Role of inhaled particles in disease development: Inhaled mineral particles deposit in the respiratory tract, with particles over 5 μm reaching terminal airways and particles less than 1 μm depositing in alveoli. These particles induce inflammation, macrophage activation, and fibrosis, contributing to various lung diseases (e.g., silicosis, asbestosis).

Essential Points

  • Pneumoconiosis: Lung disease from inhalation of mineral dust, primarily coal, silica, asbestos, and beryllium. Particles >5 μm are cleared by macrophages, while particles <1 μm deposit in alveoli, causing damage and fibrosis.
  • Asbestosis: Results from prolonged asbestos exposure, characterized by fibrosis starting in lower lung zones, with clinical features including dyspnea and productive cough. X-ray shows calcific pleural plaques.
  • Silicosis: Caused by inhalation of silica, leading to nodular fibrosis in upper lung zones, egg-shell calcification, and progression to fibrotic lesions. Clinical features include breathlessness and risk of TB.
  • Role of inhaled particles: Particles less than 1 μm deposit in alveoli, causing tissue damage and fibrosis; larger particles are ingested and eliminated.
  • Impact on lung health: Occupational exposure to mineral dusts can cause fibrosis, increase susceptibility to infections like TB, and lead to respiratory failure.

Key Takeaway

Inhalation of mineral dusts during occupational activities plays a critical role in the development of environmental lung diseases, with particle size influencing deposition, tissue damage, and fibrosis, ultimately impairing lung function.

10. Pneumoconiosis and asbestosis

Key Concepts & Definitions

  • Pneumoconiosis: Lung disease caused by inhalation of mineral dust, mainly coal dust, silica, asbestos, and beryllium. Particles more than 5 um reach terminal airways and are cleared by alveolar macrophages, while particles less than 1 um deposit in alveoli, causing damage and fibrosis. (Source)

  • Asbestosis: A form of pneumoconiosis resulting from prolonged asbestos exposure, characterized by fibrosis starting in the lower lung zones, with clinical features of dyspnea and productive cough. X-ray shows calcific pleural plaques. (Source)

  • Silicosis: Lung disease caused by inhalation of silica dust, leading to damage of lung macrophages. Lesions are pale to blackened nodules in upper lung zones, progressing to fibrotic lesions and egg-shell calcification in hilar lymph nodes and pleura. (Source)

  • Particles less than 1 um: Deposit in alveoli, damage alveolar tissue, and promote fibrosis formation. (Source)

  • Pleural plaques: Calcific deposits on the pleura associated with asbestos exposure, indicating asbestos-related fibrosis. (Source)

Essential Points

  • Mineral dust inhalation causes lung disease primarily through particles less than 1 um depositing in alveoli, leading to fibrosis.
  • Coal dust, silica, asbestos, and beryllium are the main mineral dusts involved.
  • Particles >5 um are usually cleared by macrophages, but particles <1 um cause direct alveolar damage and fibrosis.
  • Asbestosis begins in the lower lung zones, with clinical symptoms of dyspnea and productive cough; X-ray reveals calcific pleural plaques.
  • Silicosis manifests as nodules in upper lung zones, with characteristic egg-shell calcification, and can progress to respiratory failure and cor pulmonale.
  • Silicotic lungs are more susceptible to tuberculosis.

Key Takeaway

Inhalation of mineral dust particles less than 1 um deposits in alveoli, causing alveolar damage and fibrosis, with asbestos exposure also leading to pleural plaques and fibrosis.

11. Silicosis features and effects

Key Concepts & Definitions

  • Silicosis: A lung disease caused by inhalation of silica particles, leading to nodular fibrosis predominantly in the upper zones of the lungs. It involves the formation of pale to blackened nodules and progresses to fibrotic lesions, with the potential to develop egg-shell calcification in hilar lymph nodes. Silicosis increases susceptibility to tuberculosis (TB).

  • Nodular fibrosis in upper lung zones: The formation of fibrous nodules mainly in the upper parts of the lungs due to silica particle deposition and the subsequent fibrotic response.

  • Egg-shell calcification: A characteristic radiological feature where calcification occurs in the rim of hilar lymph nodes, giving a shell-like appearance, often associated with silicosis.

  • Progression to fibrotic lesions: The evolution of initial nodular fibrosis into more extensive, dense fibrotic tissue, leading to stiffening and scarring of lung tissue.

  • Susceptibility to TB: Silicosis damages lung macrophages, impairing immune defenses, which makes the lungs more vulnerable to tuberculosis infection.

  • Clinical features: Symptoms include breathlessness and respiratory failure, often as the disease advances.

Essential Points

  • Silicosis involves nodular fibrosis primarily in the upper lung zones, with lesions that can become dense and fibrotic over time.

  • Egg-shell calcification is a hallmark radiological sign, indicating calcification around hilar lymph nodes.

  • The disease progresses from initial nodular formation to extensive fibrotic tissue, impairing lung function.

  • Silicosis increases the risk of tuberculosis due to damage to lung macrophages, which are crucial for immune defense.

  • Clinical presentation includes breathlessness and can lead to respiratory failure in advanced stages.

Key Takeaway

Silicosis is a progressive fibrotic lung disease characterized by nodular fibrosis in the upper zones, egg-shell calcification, and increased susceptibility to TB, with clinical features of breathlessness and potential respiratory failure.

12. Parenchymal lung diseases and fibrosis

Key Concepts & Definitions

Interstitium inflammation: The inflammatory response occurring within the lung interstitium, which involves the alveolar walls and supporting tissue, leading to tissue damage and potential fibrosis.

Fibrosis in parenchymal lung diseases: The formation of excess fibrous connective tissue within the lung parenchyma as a result of ongoing inflammation or injury, causing scarring, lung distortion, and impaired gas exchange.

Pathogenesis involving alveolitis, fibrosis, and lung distortion: The process begins with alveolitis—inflammation of alveolar spaces—spreading to the interstitium, resulting in fibrosis. The fibrotic tissue causes scarring and distortion of lung architecture, leading to compromised lung function.

Key Dates

(Absent in provided content; no section generated)

Synthesis Tables

AspectTuberculosis PathophysiologyReinfection & ReactivationSpread of TuberculosisLung Cancer Types & SpreadEnvironmental Lung DiseasesParenchymal Lung Diseases & Fibrosis
Key ProcessGranuloma formation with caseous necrosis; immune response involving alveolar macrophagesReactivation: dormant bacteria become active; Reinfection: new bacterial infectionDirect spread, via bronchi, pulmonary veins, lymphaticsTypes: Small cell, non-small cell; spread via local invasion, lymphatics, bloodInhalation of environmental agents (e.g., asbestos, silica) leading to lung damageFibrosis from chronic injury, inflammation, or exposure
Main FeaturesOrganized immune cell collection, caseous necrosisReactivation: occurs in immunocompromised; Reinfection: new exposureLocalized or systemic; can cause disseminated diseaseSmall cell: aggressive; Non-small cell: includes adenocarcinoma, squamous cellAsbestosis: pleural plaques, fibrosis; Silicosis: nodular fibrosisHoneycombing, reticulations, progressive fibrosis
Author/Key Concept"Granuloma formation" (implied immune response)"Reactivation" and "Reinfection" (definitions)"Blood-borne dissemination" (via pulmonary veins)Know authors on "Lung cancer types"Know "Asbestosis features" and "Silicosis effects"Know "Fibrosis" features and causes

Common Pitfalls & Confusions

  1. Confusing granuloma with other tissue masses; remember granulomas are organized immune responses with caseous necrosis.
  2. Mistaking reactivation for reinfection; reactivation involves dormant bacteria within granulomas, reinfection involves new bacteria.
  3. Overlooking the routes of TB spread; ensure understanding of direct, hematogenous, lymphatic, and airway spread.
  4. Misidentifying clinical features; systemic symptoms like night sweats are key alongside cough and hemoptysis.
  5. Confusing radiological features; cavitation indicates active disease, consolidation may be present in various infections.
  6. Misunderstanding TB diagnosis; Mantoux test indicates exposure, not necessarily active disease.
  7. Confusing types of lung cancer; small cell is more aggressive, non-small cell includes adenocarcinoma and squamous cell carcinoma.

Exam Checklist

  • Understand the immune response in TB, especially granuloma formation and caseous necrosis.
  • Know the processes of reactivation and reinfection, including their clinical significance.
  • Describe the routes of TB spread: direct, via bronchi, blood (pulmonary veins), and lymphatics.
  • Recognize clinical features: chronic cough, hemoptysis, systemic symptoms, and radiological signs like cavitation and consolidation.
  • Be familiar with TB diagnosis methods: Mantoux test, ESR, chest X-ray.
  • Know the main features of bronchiectasis, including causes (e.g., infections, obstruction) and morphology.
  • Understand bronchiectasis clinical presentation and management strategies.
  • Differentiate lung cancer types: small cell vs. non-small cell, and their patterns of spread.
  • Recognize environmental lung diseases, especially asbestosis and silicosis, including their features and effects.
  • Know the causes, features, and effects of silicosis and asbestosis.
  • Comprehend the pathogenesis, features, and radiological findings of parenchymal lung diseases and fibrosis.

Teste tes connaissances

Teste tes connaissances sur Lung Pathology and Disease Mechanisms avec 7 questions à choix multiples et corrections détaillées.

1. How does granuloma formation differ from caseous necrosis in the pathophysiology of tuberculosis?

2. What is a key characteristic feature of granulomas in tuberculosis?

Faire le QCM →

Révisez avec les flashcards

Mémorisez les concepts clés de Lung Pathology and Disease Mechanisms avec 9 flashcards interactives.

Tuberculosis — immune response?

Granuloma formation with caseous necrosis

Granuloma formation — purpose?

Containment of Mycobacterium tuberculosis.

Reactivation vs Reinfection — difference?

Reactivation: dormant bacteria become active; Reinfection: new bacterial infection occurs

Voir les flashcards →

Cours similaires

Crée tes propres fiches de révision

Importe ton cours et l'IA génère fiches, QCM et flashcards en 30 secondes.

Générateur de fiches